Verition Fund Management’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,113
Closed -$237K 605
2014
Q4
$237K Sell
1,113
-177
-14% -$35.2K 0.05% 199
2014
Q3
$230K Sell
1,290
-33,710
-96% -$5.6M 0.03% 514
2014
Q2
$5.92M Buy
35,000
+30,781
+730% +$4.79M 0.63% 23
2014
Q1
$524K Buy
+4,219
New +$514K 0.08% 164

Other funds holding AGN

Verition Fund Management's AGN Position: Q1 2015 in Review

Verition Fund Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,113 shares — an estimated $237K sold.

Verition Fund Management first reported a position in AGN in Q1 2014 and held it in 4 quarters. The position peaked at $5.92M in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Verition Fund Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Verition Fund Management sold 1,113 Allergan Inc shares in Q1 2015, an estimated $237K.
  • Verition Fund Management first reported a position in Allergan Inc in Q1 2014 and held it in 4 quarters.
  • Verition Fund Management's Allergan Inc position peaked at $5.92M in Q2 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Verition Fund Management's 13F filing for Q1 2015, filed 15 May 2015.